A Mindfulness-Based Resiliency Program for Caregivers of Patients With Severe Acute Brain Injury Transitioning Out of Critical Care: Protocol for an Open Pilot Trial.
brain injury
caregiver
coma
decision-making
emotional distress
emotional support
intervention
mental health
mindfulness
resilience
self-report assessment
severe acute brain injury
support
Journal
JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504
Informations de publication
Date de publication:
25 Oct 2023
25 Oct 2023
Historique:
received:
17
07
2023
accepted:
27
09
2023
medline:
25
10
2023
pubmed:
25
10
2023
entrez:
25
10
2023
Statut:
epublish
Résumé
Caregivers of patients with severe acute brain injuries (SABI) that lead to coma and require intensive care unit (ICU) treatment often experience chronic emotional distress. To address this need, we developed the Coma Family (COMA-F) program, a mindfulness-based resiliency intervention for these caregivers. We will conduct an open pilot trial of COMA-F (National Institutes of Health Stage IA). Here we describe our study protocol and proposed intervention content. We will enroll 15 caregivers of patients with SABIs during their loved one's hospital course from 3 enrollment centers. A clinical psychologist will deliver the COMA-F intervention (6 sessions) over Zoom (Zoom Video Communications, Inc) or in person. We will iterate COMA-F after each caregiver completes the intervention and an exit interview. English-speaking adults who have emotional distress confirmed by the clinical team and are the primary caregivers of a patient with SABI are eligible. The adult patient must have been admitted to the neuro-ICU for SABI and (1) have had a Glasgow Coma Scale score below 9 while not intubated or an inability to follow meaningful commands while intubated at any point during their hospitalization for >24 hours due to SABI; (2) will be undergoing either tracheostomy or percutaneous endoscopic or surgical gastrostomy tube placement or have already received one or both; and (3) have a prognosis of survival >3 months. We will identify eligible caregivers through screening patients' medical records and through direct referrals from clinicians in the neuro-ICU. During the intervention we will teach caregivers mind-body and resilience skills, including deep breathing, mindfulness, meditation, dialectical thinking, acceptance, cognitive restructuring, effective communication, behavioral activation, and meaning-making. Caregivers will complete self-report assessments (measures of emotional distress and resilience) before and after the intervention. Primary outcomes are feasibility (recruitment, quantitative measures, adherence, and therapist fidelity) and acceptability (treatment satisfaction, credibility, and expectancy). We will conduct brief qualitative exit interviews to gather feedback on refining the program and study procedures. We will examine frequencies and proportions to determine feasibility and acceptability and will analyze qualitative exit interview data using thematic analysis. We will also conduct 2-tailed t tests to explore signals of improvement in emotional distress and treatment targets. We will then conduct an explanatory-sequential mixed methods analysis to integrate quantitative and qualitative data to refine the COMA-F manual and study procedures. This study has been approved by the institutional review board at 1 of the 3 enrollment centers (2023P000536), with approvals at the other 2 centers pending. We anticipate that the study will be completed by late 2024. We will use our findings to refine the COMA-F intervention and prepare for a feasibility randomized controlled trial. ClinicalTrials.gov NCT05761925; https://clinicaltrials.gov/study/NCT05761925. PRR1-10.2196/50860.
Sections du résumé
BACKGROUND
BACKGROUND
Caregivers of patients with severe acute brain injuries (SABI) that lead to coma and require intensive care unit (ICU) treatment often experience chronic emotional distress. To address this need, we developed the Coma Family (COMA-F) program, a mindfulness-based resiliency intervention for these caregivers.
OBJECTIVE
OBJECTIVE
We will conduct an open pilot trial of COMA-F (National Institutes of Health Stage IA). Here we describe our study protocol and proposed intervention content.
METHODS
METHODS
We will enroll 15 caregivers of patients with SABIs during their loved one's hospital course from 3 enrollment centers. A clinical psychologist will deliver the COMA-F intervention (6 sessions) over Zoom (Zoom Video Communications, Inc) or in person. We will iterate COMA-F after each caregiver completes the intervention and an exit interview. English-speaking adults who have emotional distress confirmed by the clinical team and are the primary caregivers of a patient with SABI are eligible. The adult patient must have been admitted to the neuro-ICU for SABI and (1) have had a Glasgow Coma Scale score below 9 while not intubated or an inability to follow meaningful commands while intubated at any point during their hospitalization for >24 hours due to SABI; (2) will be undergoing either tracheostomy or percutaneous endoscopic or surgical gastrostomy tube placement or have already received one or both; and (3) have a prognosis of survival >3 months. We will identify eligible caregivers through screening patients' medical records and through direct referrals from clinicians in the neuro-ICU. During the intervention we will teach caregivers mind-body and resilience skills, including deep breathing, mindfulness, meditation, dialectical thinking, acceptance, cognitive restructuring, effective communication, behavioral activation, and meaning-making. Caregivers will complete self-report assessments (measures of emotional distress and resilience) before and after the intervention. Primary outcomes are feasibility (recruitment, quantitative measures, adherence, and therapist fidelity) and acceptability (treatment satisfaction, credibility, and expectancy). We will conduct brief qualitative exit interviews to gather feedback on refining the program and study procedures. We will examine frequencies and proportions to determine feasibility and acceptability and will analyze qualitative exit interview data using thematic analysis. We will also conduct 2-tailed t tests to explore signals of improvement in emotional distress and treatment targets. We will then conduct an explanatory-sequential mixed methods analysis to integrate quantitative and qualitative data to refine the COMA-F manual and study procedures.
RESULTS
RESULTS
This study has been approved by the institutional review board at 1 of the 3 enrollment centers (2023P000536), with approvals at the other 2 centers pending. We anticipate that the study will be completed by late 2024.
CONCLUSIONS
CONCLUSIONS
We will use our findings to refine the COMA-F intervention and prepare for a feasibility randomized controlled trial.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov NCT05761925; https://clinicaltrials.gov/study/NCT05761925.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
UNASSIGNED
PRR1-10.2196/50860.
Identifiants
pubmed: 37878376
pii: v12i1e50860
doi: 10.2196/50860
pmc: PMC10632918
doi:
Banques de données
ClinicalTrials.gov
['NCT05761925']
Types de publication
Journal Article
Langues
eng
Pagination
e50860Informations de copyright
©Alexander Mattia Presciutti, Emily Woodworth, Elizabeth Rochon, Molly Neale, Melissa Motta, Joseph Piazza, Ana-Maria Vranceanu, David Yi-Gin Hwang. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 25.10.2023.
Références
Pharmacoeconomics. 2019 Apr;37(4):475-499
pubmed: 30887469
Prof Case Manag. 2020 Jul/Aug;25(4):213-219
pubmed: 32453176
Neurocrit Care. 2021 Jul;35(Suppl 1):4-23
pubmed: 34236619
Qual Health Res. 2013 Feb;23(2):231-40
pubmed: 23188382
J Health Psychol. 2016 Jul;21(7):1197-206
pubmed: 25253627
Neurocrit Care. 2015 Aug;23(1):131-41
pubmed: 25990137
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
J Clin Psychol. 2006 Dec;62(12):1445-67
pubmed: 17019673
Neurocrit Care. 2022 Aug;37(1):326-350
pubmed: 35534661
Crit Care Explor. 2022 Mar 04;4(3):e0648
pubmed: 35265851
Crit Care Med. 2021 Sep 1;49(9):1414-1426
pubmed: 33826586
Neurocrit Care. 2021 Jul;35(Suppl 1):1-3
pubmed: 34236618
Clinics (Sao Paulo). 2012;67(4):341-5
pubmed: 22522759
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86
pubmed: 11132119
Brain Inj. 2015;29(4):473-80
pubmed: 25517138
Stroke. 1988 Dec;19(12):1497-500
pubmed: 3201508
J Cardiopulm Rehabil. 2003 Nov-Dec;23(6):398-403
pubmed: 14646785
J Palliat Med. 2017 Feb;20(2):170-176
pubmed: 27763820
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Neurocrit Care. 2023 Jul 31;:
pubmed: 37523110
Brain Commun. 2022 Sep 01;4(5):fcac188
pubmed: 36132425
Am J Respir Crit Care Med. 2012 Sep 15;186(6):480-6
pubmed: 22822020
JAMA Netw Open. 2020 Oct 1;3(10):e2020807
pubmed: 33052404